Research

Published Manuscripts

• Silvis J, Rowe CL, Dobbins S, Haq N, Vittinghoff E, McMahan VM, Appa A, Coffin PO. Engagement in HIV care and viral suppression following changes in long-term opioid therapy for treatment for chronic pain. AIDS Behav. 2022 Apr 5.
• Tierney HR, Rowe CL, Coffa DA, Sarnaik S, Coffin PO, Snyder HR. Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge. J Addict Med. 2022 Mar-Apr 01;16(2):169-176.
• Li CX, Matthay EC, Rowe C, Bradshaw PT, Ahern J. Conducting density-sampled case-control studies using survey data with complex sampling designs: A simulation study. Ann Epidemiol. 2022 Jan;65:109-115.
• Rowe CL, Eagen K, Ahern J, Faul M, Hubbard A, Coffin P. Evaluating the Effects of Opioid Prescribing Policies on Patient Outcomes in a Safety-net Primary Care Clinic. J Gen Intern Med. 2022 Jan;37(1):117-124.
• Rowe CL, Ahern J, Hubbard A, Coffin PO. Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program. J Subst Abuse Treat. 2022 Jan;132:108452.
• Suen LW, McMahan VM, Rowe C, Bhardwaj S, Knight K, Kushel MB, Santos GM, Coffin P. Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use. J Am Board Fam Med. Nov-Dec 2021;34(6):1082-1095.
• Zimmerman SC, Matthay EC, Rudolph KE, Goin DE, Farkas K, Rowe CL, Ahern J. California’s Mental Health Services Act and Mortality Due to Suicide, Homicide, and Acute Effects of Alcohol: A Synthetic Control Application. Am J Epidemiology. 2021 Oct 1;190(10):2107-2115.
• Rowe CL, Matthay EC, Ahern J. Nonfatal Assault Injury Trends in California, 2005 to 2015. J Interpers Violence. 2021 Jul;36(13-14):NP7236-NP7245.
• Jain JP, Offer C, Rowe C, Turner C, Dawson-Rose C, Hoffmann T, Santos GM. The Psychosocial Predictors and Day-Level Correlates of Substance Use Among Participants Recruited via an Online Crowdsourcing Platform in the United States: Daily Diary Study. JMIR Public Health Surveill. 2021 Apr 27;7(4):e23872
• Rowe CL, Santos GM, Kornbluh W, Bhardwaj S, Faul M, Coffin PO. Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report. Drug Alcohol Depend. 2021 Apr 1;221:108537.
• Holmen JE, Kim L, Cikesh B, Kirley PD, Chai SJ, Bennett NM, Felsen CB, Ryan P, Monroe M, Anderson EJ, Openo KP, Como-Sabetti K, Bye E, Talbot HK, Schaffner W, Muse A, Barney GR, Whitaker M, Ahern J, Rowe C, Langley G, Reingold A. Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015-2017. BMC Infect Dis. 2021 Mar 23;21(1):293.
• Appa A, Rowe C, Hessol NA, Coffin P. Beyond Overdose: Drug-Related Deaths in People With and Without HIV in San Francisco, 2007-2018. Open Forum Infect Dis. 2020 Nov 18;7(12):ofaa565.
• Coffin PO, Rowe C, Oman N, Sinchek K, Santos GM, Faul M, Bagnulo R, Mohamed D, Vittinghoff E. Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain. PLoS One. 2020 May 4;15(5):e0232538.
• Rowe CL, Riley ED, Eagen K, Zevin B, Coffin PO. Drug overdose mortality among residents of single room occupancy buildings in San Francisco, California, 2010-2017. Drug Alcohol Depend. 2019 Nov 1; 204:107571. 
• Rowe C, Wheeler E, Stephen Jones T, Yeh C, Coffin PO. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015. J Urban Health. 2019 Feb; 96(1):6-11. 
• Rowe C, Vittinghoff E, Colfax G, Coffin PO, Santos GM. Correlates of Validity of Self-Reported Methamphetamine Use among a Sample of Dependent Adults. Subst Use Misuse. 2018 Aug 24; 53(10):1742-1755. 
• Santos GM, Rowe C, Hern J, Walker JE, Ali A, Ornelaz M, Prescott M, Coffin P, McFarland W, Raymond HF. Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco. PLoS One. 2018; 13(8):e0202170.
• Rowe C, Wheeler E, Vittinghoff E, Santos GM, Behar E, Coffin PO. Quantity fluctuations of illicitly used opioids and overdose risk. Int J Drug Policy. 2018 Aug; 58:64-70.
• Turner C, Chandrakumar D, Rowe C, Santos GM, Riley ED, Coffin PO. Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. Drug Alcohol Depend. 2018 Apr 1; 185:305-312.
• Hurstak E, Rowe C, Turner C, Behar E, Cabugao R, Lemos NP, Burke C, Coffin P. Using medical examiner case narratives to improve opioid overdose surveillance. Int J Drug Policy. 2018 Apr; 54:35-42. 
• Smith-Bernardin S, Rowe C, Behar E, Geier M, Washington S, Santos GM, Euren J, Martin J, Gleghorn A, Coffin PO. Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study. J Subst Abuse Treat. 2018 Feb; 85:109-115. 
• Coffin PO, Santos GM, Matheson T, Behar E, Rowe C, Rubin T, Silvis J, Vittinghoff E. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLoS One. 2017; 12(10):e0183354.
• Rowe C, Matheson T, Das M, DeMicco E, Herbst JH, Coffin PO, Santos GM. Correlates of recent HIV testing among substance-using men who have sex with men. Int J STD AIDS. 2017 May; 28(6):594-601.
• Rowe C, Vittinghoff E, Santos GM, Behar E, Turner C, Coffin PO. Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department. Acad Emerg Med. 2017 Apr; 24(4):475-483.
• Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM. Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco. J Subst Abuse Treat. 2017 Apr; 75:43-48.
• Rowe C, Santos GM, Raymond HF, Coffin PO. Social mixing and correlates of injection frequency among opioid use partnerships. Int J Drug Policy. 2017 Mar; 41:80-88.
• Behar E, Rowe C, Santos GM, Coffa D, Turner C, Santos NC, Coffin PO. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain. J Gen Intern Med. 2017 Mar; 32(3):291-295.
• Behar E, Rowe C, Santos GM, Santos N, Coffin PO. Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco. Fam Med. 2017 Feb; 49(2):122-126.
• Rowe C, Liou T, Vittinghoff E, Coffin PO, Santos GM. Binge drinking concurrent with anal intercourse and condom use among men who have sex with men. AIDS Care. 2016 Dec; 28(12):1566-1570.
• Rowe C, Gunier R, Bradman A, Harley KG, Kogut K, Parra K, Eskenazi B. Residential proximity to organophosphate and carbamate pesticide use during pregnancy, poverty during childhood, and cognitive functioning in 10-year-old children. Environ Res. 2016 Oct; 150:128-137.
• Behar E, Rowe C, Santos GM, Murphy S, Coffin PO. Primary Care Patient Experience with Naloxone Prescription. Ann Fam Med. 2016 Sep; 14(5):431-6.
• Coffin PO, Behar E, Rowe C, Santos GM, Coffa D, Bald M, Vittinghoff E. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016 Aug 16; 165(4):245-52.
• Rowe C, Hern J, DeMartini A, Jennings D, Sommers M, Walker J, Santos GM. Concordance of Text Message Ecological Momentary Assessment and Retrospective Survey Data Among Substance-Using Men Who Have Sex With Men: A Secondary Analysis of a Randomized Controlled Trial. JMIR Mhealth Uhealth. 2016 May 26; 4(2):e44.
• Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL. Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. J Acquir Immune Defic Syndr. 2016 May 1; 72(1):21-30.
• Rowe C, Santos GM, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016 Feb 1; 159:234-9.
• Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. J Urban Health. 2016 Feb; 93(1):117-30. 
• Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015 Aug; 110(8):1301-10.
• Coffin PO, Rowe C, Santos GM. Novel interventions to prevent HIV and HCV among persons who inject drugs. Curr HIV/AIDS Rep. 2015 Mar; 12(1):145-63.
• Behar E, Santos GM, Wheeler E, Rowe C, Coffin PO. Brief overdose education is sufficient for naloxone distribution to opioid users. Drug Alcohol Depend. 2015 Mar 1; 148:209-12.
• Rowe C, Santos GM, McFarland W, Wilson EC. Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area. Drug Alcohol Depend. 2015 Feb 1; 147:160-6.